Russell Investments Group
FSTX

Russell Investments Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Russell Investments Group’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-432,125
Closed -$2.73M – 3429
2022
Q4 		$2.73M Sell
432,125
-58,587
-12% -$324K 0.01% 1398
2022
Q3 		$2.51M Buy
490,712
+116,162
+31% +$729K 0.01% 1425
2022
Q2 		$2.34M Sell
374,550
-226,844
-38% -$764K ﹤0.01% 1506
2022
Q1 		$2.13M Buy
601,394
+356,317
+145% +$1.32M ﹤0.01% 1613
2021
Q4 		$1.23M Buy
245,077
+67,791
+38% +$409K ﹤0.01% 2047
2021
Q3 		$1.3M Buy
177,286
+2,513
+1% +$17.2K ﹤0.01% 2071
2021
Q2 		$1.5M Buy
+174,773
New +$1.49M ﹤0.01% 2090

Russell Investments Group's FSTX Position: Q1 2023 in Review

Russell Investments Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 432,125 shares — an estimated $2.73M sold.

Russell Investments Group first reported a position in FSTX in Q2 2021 and held it in 7 quarters. The position peaked at $2.73M in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Russell Investments Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Russell Investments Group sold 432,125 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $2.73M.
  • Russell Investments Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Russell Investments Group's F-star Therapeutics, Inc. Common Stock position peaked at $2.73M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Russell Investments Group's 13F filing for Q1 2023, filed 9 May 2023.